BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15767674)

  • 1. Ikaros SUMOylation: switching out of repression.
    Gómez-del Arco P; Koipally J; Georgopoulos K
    Mol Cell Biol; 2005 Apr; 25(7):2688-97. PubMed ID: 15767674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.
    Koipally J; Renold A; Kim J; Georgopoulos K
    EMBO J; 1999 Jun; 18(11):3090-100. PubMed ID: 10357820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
    Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
    Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumoylation Inhibits the Growth Suppressive Properties of Ikaros.
    Apostolov A; Litim-Mecheri I; Oravecz A; Goepp M; Kirstetter P; Marchal P; Ittel A; Mauvieux L; Chan S; Kastner P
    PLoS One; 2016; 11(6):e0157767. PubMed ID: 27315244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P300 transcriptional repression is mediated by SUMO modification.
    Girdwood D; Bumpass D; Vaughan OA; Thain A; Anderson LA; Snowden AW; Garcia-Wilson E; Perkins ND; Hay RT
    Mol Cell; 2003 Apr; 11(4):1043-54. PubMed ID: 12718889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumoylation of CoREST modulates its function as a transcriptional repressor.
    Muraoka A; Maeda A; Nakahara N; Yokota M; Nishida T; Maruyama T; Ohshima T
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1031-5. PubMed ID: 18854179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding.
    Cobb BS; Morales-Alcelay S; Kleiger G; Brown KE; Fisher AG; Smale ST
    Genes Dev; 2000 Sep; 14(17):2146-60. PubMed ID: 10970879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO promotes HDAC-mediated transcriptional repression.
    Yang SH; Sharrocks AD
    Mol Cell; 2004 Feb; 13(4):611-7. PubMed ID: 14992729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
    Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
    Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.
    Sabbattini P; Lundgren M; Georgiou A; Chow C; Warnes G; Dillon N
    EMBO J; 2001 Jun; 20(11):2812-22. PubMed ID: 11387214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
    Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
    Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of pokemon 1 activity by sumoylation.
    Roh HE; Lee MN; Jeon BN; Choi WI; Kim YJ; Yu MY; Hur MW
    Cell Physiol Biochem; 2007; 20(1-4):167-80. PubMed ID: 17595526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular dissection of the repression circuitry of Ikaros.
    Koipally J; Georgopoulos K
    J Biol Chem; 2002 Aug; 277(31):27697-705. PubMed ID: 12015313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO modification regulates the transcriptional activity of MAML1.
    Lindberg MJ; Popko-Scibor AE; Hansson ML; Wallberg AE
    FASEB J; 2010 Jul; 24(7):2396-404. PubMed ID: 20203086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator.
    Trinh LA; Ferrini R; Cobb BS; Weinmann AS; Hahm K; Ernst P; Garraway IP; Merkenschlager M; Smale ST
    Genes Dev; 2001 Jul; 15(14):1817-32. PubMed ID: 11459831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide.
    Singh S; Pradhan AK; Chakraborty S
    Biochim Biophys Acta; 2013 Oct; 1833(10):2357-68. PubMed ID: 23770046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport.
    Pichler A; Melchior F
    Traffic; 2002 Jun; 3(6):381-7. PubMed ID: 12010456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.